课题基金 / 基金详情

寡肽/组氨酸转运体介导细菌肽聚糖降解产物跨溶酶体转运致炎症性肠病研究

批准号:
81573492
项目类别:
面上项目
资助金额:
65.0 万元
负责人:
蒋惠娣
依托单位:
学科分类:
药物代谢与药物动力学
结题年份:
2019
批准年份:
2015
项目状态:
已结题
项目参与者:
李丽萍、杨菲、王金海、David E. Smith、汪宇清、宋飞凤、周思思、杜巍娟

项目摘要

结项摘要

项目成果

蒋惠娣的其他基金

相似基金

相关文献

中文摘要
IBD是一组病因不十分明确的非特异性肠道炎症性疾病,无有效治疗措施。IBD与细胞质NODs密切相关,推测细菌肽聚糖降价产物MDP/tri-DAP进入细胞质,被NODs识别,激活炎症反应。但MDP/DAP进入细胞质机制不清。寡肽转运体家族(POTs)可转运二/三肽及拟肽物质,而MDP/DAP结构与POTs底物类似。我们的研究显示,小鼠远端结肠及结肠粘膜固有层单个核细胞寡肽/组氨酸转运体1,2(PHT1/2)蛋白表达高,且IBD时PHT2显著上调。基于PHT1/2位于溶酶体膜,推测细菌被肠道免疫细胞内吞后,在溶酶体内消化,肽聚糖降解产物MDP/DAP经PHT1/2转运入细胞质,与NODs作用。本课题拟在前期研究基础上,应用正常/IBD小鼠、转基因细胞/小鼠以及临床样本,考察PHT1/2在肠道及免疫细胞中的表达,探究其在MDP/DAP转运及IBD中的作用,为阐明IBD发病机制、靶点发现提供依据。
英文摘要
Inflammatory bowel disease ( IBD) is a nonspecific intestinal inflammatory disease, the underlying basis of the pathogenesis is not yet clear but may involve persistent bacterial infection, a defective mucosal barrier, or an imbalance in the regulation of immune response. Due to the contribution of NODs to the risk of IBD, it was deduced that degradation products of peptidoglycan of bacteria cell wall, such as muramyl dipeptide (MDP) and L-Ala-γ-D-Glu-meso-diaminopimelic acid (tri-DAP) , transported into cytosol, recognized by NODs and subsequently activated the inflammatory response. However, the mechanism of MDP, tri-DAP transport has not been clarified. Proton-coupled oligopeptide transporters (POTs) can transport the di-/tri-peptides and mimic peptide compounds, due to the similarity of the structures of MDP and tri-DAP, it implies that they might be transported by POTs. Our previous study showed that the distal colon and lamina propia mononuclear cells (LPMCs) of the colon from normal mice expressed oligopeptide and histidine transporter 1 and 2 (PHT1 and PHT2) protein, and the PHT2 was significantly up-regulated in IBD mice, but not expressed PEPT1 and PEPT2 proteins. Since PHT1 and PHT2 are localized on lysosomal membrane but not cellular membrane, our hypothesis is that PHT1 and PHT2 may transport MDP, tri-DAP from lysosomes to cytosol, after the bacteria was endocytosed by immune cells and degraded in lysosomes, and subsequently interact with NODs. The present proposal will emply normal/IBD mice, transfected cells/mice and clinical samples, to delineate the protein expression of PEPT1/2 and PHT1/2 in mouse/human colonic tissues and immune cells, to elucidate the role of PHT1/2 in the transport of MDP, tri-DAP, and in the mechanism of IBD. The study will provide the useful information for elucidation of IBD mechanism and discovery of new drug target.
IBD是一组病因不十分明确的非特异性肠道炎症性疾病,目前无有效治疗措施。已发现IBD与细胞质NODs密切相关,故推测溶酶体内的细菌肽聚糖降价产物MDP/tri-DAP进入细胞质,被NODs识别,激活炎症反应。因MDP/tri-DAP为拟肽类物质,而寡肽转运体家族(POTs)可介导二/三肽及拟肽物质的跨膜转运,且PHT2定位于溶酶体膜。因此,探究PHT2在介导MDP/DAP跨溶酶体膜的转运以及与IBD的关系,对阐明其作为潜在的IBD治疗靶点具有重要意义。本项目阐明了小鼠肠道中寡肽转运体的表达,发现了DSS诱导的溃疡性结肠炎小鼠结肠中PHT2表达(mRNA及蛋白水平)显著高于正常小鼠结肠,临床IBD患者的结肠中也发现了同样的现象(mRNA 水平);应用基因突变及重组表达技术,构建将人源PHT1、PHT2(hPHT1、hPHT2)稳定表达于细胞膜的转基因细胞模型,并应用上述模型,阐明了MDP、tri-DAP的底物特性,筛选获得了一系列hPHT1、hPHT2底物/抑制剂,获得了hPHT1、hPHT2经典底物Gly-sar、组氨酸的摄取动力学参数。此外,我们从基因及蛋白水平阐明了巨噬细胞中PHT2的表达可被TLR2、TLR4、TLR7和TLR9配体,经NF-κB、MAPK和IRF3通路上调;应用基因沉默/过表达技术,发现了PHT2在TLR4配体LPS诱导IL-6和TNF-α生成中的抑制/促进作用。上述研究提示,PHT2/1可介导MDP/tri-DAP由溶酶体转运至细胞质,IBD的发生发展与PHT2的表达水平相关,PHT2在IBD及炎症发生发展中可能具有重要作用。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Substrate Transport Properties of the Human Peptide/Histidine Transporter PHT2 in Transfected MDCK Cells
转染 MDCK 细胞中人肽/组氨酸转运蛋白 PHT2 的底物转运特性
DOI: 10.1016/j.xphs.2019.06.016
发表时间: 2019
期刊: Journal of Pharmaceutical Sciences
影响因子: 3.8
作者: [Wang Yuqing, Li Ping, Song Feifeng, Yang Xi, Weng Yayun, Ma Zhiyuan, Wang Lu, Jiang Huidi]
通讯作者: Jiang Huidi
DOI: 10.1021/acs.molpharmaceut.7b00728
发表时间: 2018-02-05
期刊: Molecular pharmaceutics
影响因子: 4.9
作者: [Song F, Hu Y, Wang Y, Smith DE, Jiang H]
通讯作者: Jiang H
Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.
有机阴离子转运蛋白2和平衡核苷转运蛋白1在非妊娠和妊娠期间恩替卡韦的肝脏处置和抗病毒活性中的作用
DOI: 10.1111/bph.14756
发表时间: 2019
期刊: British Journal of Pharmacology
影响因子: 7.3
作者: [Zhiyuan Ma, Shuanghui Lu, Dongli Sun, Mengru Bai, Ting Jiang, Nengming Lin, Hui Zhou, Su Zeng, Huidi Jiang]
通讯作者: Huidi Jiang
Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice.
质子偶联寡肽转运蛋白在小鼠结肠组织和免疫细胞中的表达与调控
DOI: 10.1016/j.bcp.2017.12.025
发表时间: 2018-03
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Wang Y, Hu Y, Li P, Weng Y, Kamada N, Jiang H, Smith DE]
通讯作者: Smith DE
共 6 条
    基于单羧酸转运体 1/4 的乳酸化修饰调控在慢 性肾病中的作用研究
    • 批准号:
      Z24H310002
    • 项目类别:
      省市级项目
    • 资助金额:
      0.0万元
    • 批准年份:
      2024
    • 负责人:
      蒋惠娣
    • 依托单位:
    卡培他滨及其代谢物调控烟酰胺摄取转运体致手足综合征研究
    • 批准号:
      82373941
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      蒋惠娣
    • 依托单位:
    基于心肌摄取型转运体选择性抑制减轻阿霉素心脏毒性研究
    • 批准号:
      82073927
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2020
    • 负责人:
      蒋惠娣
    • 依托单位:
    基于OCTN2调控机制的新型非典型抗精神病药物致脂代谢异常研究
    • 批准号:
      81773804
    • 项目类别:
      面上项目
    • 资助金额:
      59.5万元
    • 批准年份:
      2017
    • 负责人:
      蒋惠娣
    • 依托单位:
    国内基金
    海外基金